7
7LeKang (7lk)
Operates nine offline stores and an online pharmacy platform
About 7LeKang (7lk)
7LeKang, officially known as Guangzhou Seven Lekang Medical Chain Co., Ltd., has carved out a significant presence in China's digital healthcare sector since its inception. The company was founded in Guangzhou in 2010 by Shi Zhenyang. His journey into healthcare began not in technology, but in medicine; he graduated with a clinical medicine degree in 1995 and entered the pharmaceutical industry as a drug agent in 2001. This background provided him with a foundational understanding of the medical and pharmaceutical landscapes. By 2005, he had opened his first physical pharmacy, expanding to seven locations by 2009. Inspired by the growth of e-commerce, Shi Zhenyang transitioned from brick-and-mortar to the online space, establishing 7LeKang as a licensed online pharmacy.
The firm operates as an integrated internet healthcare company, initially focusing on being a B2C pharmacy e-commerce platform. Its business model revolves around providing a wide array of products including prescription and over-the-counter drugs, nutritional supplements, medical devices, and mother-and-baby items. The company generates revenue through the online sale of these products via its own platforms and third-party marketplaces. Over the years, 7LeKang has expanded its scope significantly beyond simple e-commerce. It has developed a comprehensive ecosystem that includes an internet hospital, mobile medical services, and a chain of physical pharmacies, aiming to create a closed loop of services for patients, doctors, and pharmaceutical companies. A key strategic shift occurred in 2015 when the company ventured into internet-based medical services, with a particular focus on managing chronic diseases through its "7LeKang Doctor" app.
In a significant rebranding effort in 2018, the internet hospital division was upgraded to "Shiliu Yunyi" (Stone榴云医), concentrating on creating an integrated platform for medical consultations, pharmaceutical delivery, patient management, medical examinations, and insurance. This platform serves as a digital conduit, connecting a large network of over 400,000 doctors with millions of patients, specializing in online follow-up consultations and prescription fulfillment for chronic disease management. The platform's value proposition lies in its creation of an "doctor-patient-pharmacy" closed-loop system, which facilitates everything from online appointments and electronic prescriptions to drug delivery and payment processing. This integrated approach has attracted substantial investment over nine funding rounds from notable venture capital firms and corporations such as Sequoia China, JD.com, and others, underscoring the market's confidence in its business model.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Apr 2019 | $0 | — | General Technology Venture Capital | — |
| LATE VCOther financing | Aug 2018 | $0 | — | ShenZhen GTJA Investment Group | — |
Growth signals
Latest recorded traffic for 7LeKang (7lk) is 1.1K monthly website visits, down 35.3% over the last three months. 7LeKang (7lk)'s team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
7LeKang (7lk) in the Guangzhou ecosystem
The 7LeKang (7lk) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- SGShenZhen GTJA Investment Group
- GCGeneral Technology Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about 7LeKang (7lk) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See 7LeKang (7lk)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









